Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 18;2(2):188-198.
doi: 10.1002/hep4.1137. eCollection 2018 Feb.

Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis

Affiliations

Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis

Sakkarin Chirapongsathorn et al. Hepatol Commun. .

Abstract

We examined risks for first hospitalization and the rate, risk factors, costs, and 1-year outcome of 30-day readmission among patients admitted for complications of cirrhosis. Data were retrospectively analyzed for adult patients with cirrhosis residing in Minnesota, Iowa, or Wisconsin and admitted from 2010 through 2013 at both campuses of the Mayo Clinic Hospital in Rochester, MN. Readmission was captured at the two hospitals as well as at community hospitals in the tristate area within the Mayo Clinic Health System. The incidence of hospitalization for complications of cirrhosis was 100/100,000 population, with increasing age and male sex being the strongest risks for hospitalization. For the 2,048 hospitalized study patients, the overall 30-day readmission rate was 32%; 498 (24.3%) patients were readmitted to Mayo Clinic hospitals and 157 (7.7%) to community hospitals, mainly for complications of portal hypertension (52%) and infections (30%). Readmission could not be predicted accurately. There were 146 deaths during readmission and an additional 105 deaths up to 1 year of follow-up (50.4% total mortality). Annual postindex hospitalization costs for those with a 30-day readmission were substantially higher ($73,252) than those readmitted beyond 30 days ($62,053) or those not readmitted ($5,719). At 1-year follow-up, only 20.4% of patients readmitted within 30 days were at home. In conclusion, patients with cirrhosis have high rates of hospitalization, especially among men over 65 years, and of unscheduled 30-day readmission. Readmission cannot be accurately predicted. Postindex hospitalization costs are high; nationally, the annual costs are estimated to be more than $4.45 billion. Only 20% of patients readmitted within 30 days are home at 1 year. (Hepatology Communications 2018;2:188-198).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for enrollment and exclusion of the study patients. The tristate area is Minnesota, Iowa, and Wisconsin.
Figure 2
Figure 2
Incidence of hospitalization per 100,000 patient years for Olmsted County, Minnesota, by age, sex, and cause of cirrhosis. (A) Male sex; (B) female sex; (C) overall. Abbreviation: NASH, nonalcoholic steatohepatitis. Data point represents incidence and lines through the data point represent 95% confidence intervals.
Figure 3
Figure 3
Average standardized costs per patient for patients with and without 30‐day readmission.

References

    1. Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR Jr, Nguyen J, et al. Incidence and predictors of 30‐day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol 2011;9:254‐259. - PMC - PubMed
    1. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 2012;107:247‐252. - PMC - PubMed
    1. Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia‐Tsao G, et al. The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology 2016;64:200‐208. - PMC - PubMed
    1. Tapper EB, Halbert B, Mellinger J. Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population‐based cohort study. Clin Gastroenterol Hepatol 2016;14:1181‐1188.e2. - PubMed
    1. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266‐274. - PubMed